|
ATL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.51040000009972E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.258420E-03 |
| Normal-vs-Stage2 |
7.036000E-02 |
| Normal-vs-Stage3 |
9.93869997412133E-09 |
| Normal-vs-Stage4 |
5.9287019738008E-11 |
| Stage1-vs-Stage2 |
9.136200E-01 |
| Stage1-vs-Stage3 |
1.838810E-03 |
| Stage1-vs-Stage4 |
2.1378999999988E-05 |
| Stage2-vs-Stage3 |
5.582300E-02 |
| Stage2-vs-Stage4 |
9.862200E-03 |
| Stage3-vs-Stage4 |
2.881000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.16490000055126E-07 |
| Normal-vs-AfricanAmerican |
1.28229999951657E-07 |
| Normal-vs-Asian |
6.657600E-01 |
| Caucasian-vs-AfricanAmerican |
4.466300E-02 |
| Caucasian-vs-Asian |
3.231400E-01 |
| AfricanAmerican-vs-Asian |
4.082100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97109994992672E-09 |
| Normal-vs-Female |
1.400040E-02 |
| Male-vs-Female |
9.389800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.00929999999633E-06 |
| Normal-vs-Age(41-60Yrs) |
6.05559999999894E-05 |
| Normal-vs-Age(61-80Yrs) |
4.0284000002444E-07 |
| Normal-vs-Age(81-100Yrs) |
1.022980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.213900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.660580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.636820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.588000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.111400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.547600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.486600E-01 |
| Normal-vs-Grade 2 |
1.016050E-02 |
| Normal-vs-Grade 3 |
4.85189999288593E-09 |
| Normal-vs-Grade 4 |
1.75881531561117E-12 |
| Grade 1-vs-Grade 2 |
4.268800E-01 |
| Grade 1-vs-Grade 3 |
1.731810E-02 |
| Grade 1-vs-Grade 4 |
4.15990000000033E-05 |
| Grade 2-vs-Grade 3 |
1.018630E-03 |
| Grade 2-vs-Grade 4 |
2.65780000230365E-08 |
| Grade 3-vs-Grade 4 |
3.404200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.107800E-01 |
| Normal-vs-ccB subtype |
5.01109997941285E-09 |
| ccA subtype-vs-ccB subtype |
7.88289999942293E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.950780E-04 |
| Normal-vs-N1 |
2.201600E-03 |
| N0-vs-N1 |
4.529800E-01 |
|
|
